We develop novel ways to help cure cancer and other serious diseases.
Innovating radiopharmaceutical therapy through non-reactor based production of radioisotopes such as actinium-225 and copper-67, enabling reliable, scalable, and environmentally preferred manufacturing.
Our mission is providing patients global access to game-changing radiopharmaceuticals through integrated technology, facilities, and expertise all on one campus.
NorthStar is a patient-focused Radiopharmaceutical Contract Development and Manufacturing Organization (CDMO/CMO), advancing the availability of critical radiopharmaceuticals for cancer treatment.